ES2091359T3 - Nuevo compuesto peptidico y un procedimiento para su preparacion. - Google Patents

Nuevo compuesto peptidico y un procedimiento para su preparacion.

Info

Publication number
ES2091359T3
ES2091359T3 ES92107757T ES92107757T ES2091359T3 ES 2091359 T3 ES2091359 T3 ES 2091359T3 ES 92107757 T ES92107757 T ES 92107757T ES 92107757 T ES92107757 T ES 92107757T ES 2091359 T3 ES2091359 T3 ES 2091359T3
Authority
ES
Spain
Prior art keywords
preparation
formula
procedure
carboxy
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92107757T
Other languages
English (en)
Inventor
Hisashi Takasugi
Akito Tanaka
Hiroyoshi Sakai
Takatoshi Ishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919110298A external-priority patent/GB9110298D0/en
Priority claimed from GB929202260A external-priority patent/GB9202260D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2091359T3 publication Critical patent/ES2091359T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN COMPUESTO PEPTIDO DE LA FORMULA: DONDE R1 ES ARILO QUE PUEDE TENER UNO O MAS SUSTITUYENTES CONVENIENTES, R2 ES CARBOXI(INFERIOR)ALQUILO O CARBOXI(INFERIO)ALQUILO PROTEGIDO, R3 ES CARBOXI O CARBOXI PROTEGIDO, A1 ES ALQUILENO QUE PUEDE TENER UNO O MAS SUSTITUYENTES CONVENIENTES, A2 ES UN GRUPO DE LA FORMULA: (DONDE R4 ES ALQUILO INFERIOR), O UN GRUPO DE FORMULA: A3 ES ALQUILENO INFERIOR QUE PUEDE TENER UNO O MAS SUSTITUYENTES CONVENIENTES, T,M Y N SON CADA UNO EL MISMO O DIFERENTE DE UN ENTERO DE 0 A 1, CON LA CONDICION DE QUE A2 NO ES UN GRUPO DE LA FORMULA: FARMACEUTICAMENTE ACEPTABLE CONSIGUIENTE, SE MUESTRAN PROCESOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS INCLUYEN.
ES92107757T 1991-05-13 1992-05-08 Nuevo compuesto peptidico y un procedimiento para su preparacion. Expired - Lifetime ES2091359T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110298A GB9110298D0 (en) 1991-05-13 1991-05-13 New peptide compound and a process for the preparation thereof
GB929202260A GB9202260D0 (en) 1992-02-03 1992-02-03 New peptide compound and a process for the preparation thereof

Publications (1)

Publication Number Publication Date
ES2091359T3 true ES2091359T3 (es) 1996-11-01

Family

ID=26298895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92107757T Expired - Lifetime ES2091359T3 (es) 1991-05-13 1992-05-08 Nuevo compuesto peptidico y un procedimiento para su preparacion.

Country Status (15)

Country Link
US (1) US5574016A (es)
EP (1) EP0513675B1 (es)
JP (1) JP2606528B2 (es)
KR (1) KR920021579A (es)
CN (2) CN1043647C (es)
AT (1) ATE142641T1 (es)
AU (1) AU662522B2 (es)
CA (1) CA2068478A1 (es)
DE (1) DE69213546T2 (es)
DK (1) DK0513675T3 (es)
ES (1) ES2091359T3 (es)
GR (1) GR3021182T3 (es)
HU (2) HUT61780A (es)
IL (1) IL101839A (es)
TW (1) TW203057B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272162A (en) * 1992-07-02 1993-12-21 G. D. Searle & Co. Platelet aggregation inhibitors
US5354738A (en) * 1992-09-04 1994-10-11 G. D. Searle & Co. Platelet aggregation inhibitors
US5314902A (en) * 1993-01-27 1994-05-24 Monsanto Company Urea derivatives useful as platelet aggregation inhibitors
DE4309867A1 (de) * 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
DK0825184T3 (da) * 1993-03-29 2001-09-10 Astrazeneca Ab Heterocykliske derivater som blodpladeaggregeringsinhibitorer
NZ262942A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
ATE188611T1 (de) * 1993-11-19 2000-01-15 Searle & Co Transdermale zusammensetzung von n-(n-(5-(4- (aminoiminomethyl)phenyl-1-oxopentyl)-l-alpha- aspartyl)-l-phenylalanin oder deren esterderivaten und ihre pharmazeutischverwendbaren salze
US6387880B1 (en) 1994-10-24 2002-05-14 G.D. Searle & Co. Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L-α-aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts
CA2204006A1 (en) * 1994-11-01 1996-05-09 Youko Terajima Tetrahydroisoquinoline derivative and medical preparation containing the same
US5766932A (en) * 1995-12-20 1998-06-16 Hoechst Marion Roussel, Inc. Process for preparing N-acetyl(L)-4-cyanophenylalanine from a mixture of the corresponding D,L ethyl esters using subtilisin
UA48993C2 (uk) * 1995-12-20 2002-09-16 Авентіс Фармасьютікалз, Інк СПОСІБ ОТРИМАННЯ N-АЦЕТИЛ-(L)-4-ЦІАНОФЕНІЛАЛАНІНУ Аc-(L)-Phe(4-CN)-OH І N-АЦЕТИЛ-(L)-П-АМІДИНФЕНІЛАЛАНІН-ЦИКЛОГЕКСИЛГЛІЦИН-<font face="Symbol">b</font>-(3-N-МЕТИЛПІРИДИН)-АЛАНІНУ Аc-(L)-pАph-Сhg-PalMe(3)-NH<sub>2</sub>
JP2001131078A (ja) * 1999-11-09 2001-05-15 Iatron Lab Inc 新規活性固定化血小板及びその製造方法
DE10005631A1 (de) * 2000-02-09 2001-08-23 Max Planck Gesellschaft Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
ES2321693T3 (es) * 2000-09-06 2009-06-10 Emisphere Technologies, Inc. Compuestos de acido cianofenoxi carboxilico y composiciones para la administracion de agentes activos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
AU646838B2 (en) * 1990-03-09 1994-03-10 F. Hoffmann-La Roche Ag Acetic acid derivatives
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
US5481021A (en) * 1991-03-06 1996-01-02 G. D. Searle & Co. Phenyl amidines derivatives useful as platelet aggregation inhibitors
DE4212304A1 (de) * 1992-04-13 1993-10-14 Cassella Ag Asparaginsäurederivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
HU211266A9 (en) 1995-11-28
CN1066660A (zh) 1992-12-02
CN1043647C (zh) 1999-06-16
US5574016A (en) 1996-11-12
DE69213546D1 (de) 1996-10-17
AU1614492A (en) 1992-11-19
CN1120047A (zh) 1996-04-10
IL101839A0 (en) 1992-12-30
TW203057B (es) 1993-04-01
CA2068478A1 (en) 1992-11-14
KR920021579A (ko) 1992-12-18
HUT61780A (en) 1993-03-01
ATE142641T1 (de) 1996-09-15
JP2606528B2 (ja) 1997-05-07
HU9201578D0 (en) 1992-08-28
EP0513675B1 (en) 1996-09-11
JPH05148207A (ja) 1993-06-15
GR3021182T3 (en) 1996-12-31
EP0513675A1 (en) 1992-11-19
DE69213546T2 (de) 1997-02-27
DK0513675T3 (da) 1996-09-30
IL101839A (en) 1996-12-05
AU662522B2 (en) 1995-09-07

Similar Documents

Publication Publication Date Title
ES2091359T3 (es) Nuevo compuesto peptidico y un procedimiento para su preparacion.
DK0622361T3 (da) Heterocykliske forbindelser som bradykininantagonister
ES2121760T3 (es) Compuesto de pirazolopiridina y procedimiento para su preparacion.
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
DK0494071T3 (es)
DE69705300T2 (de) Cyclopropylalkansäurederivate
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
DE69413237D1 (en) Plättchenaggregationsinhibitoren
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
DE68926981T2 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung
ES2149193T3 (es) Compuestos heterociclicos sustituidos con alquilo.
MX9206930A (es) Nuevos compuestos
RU94019328A (ru) α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 513675

Country of ref document: ES